PropertyValue
?:abstract
  • We report a second case of methemoglobinemia and non-autoimmune hemolytic anemia after contracting the SARS-CoV-2 infection in the absence of an identifiable eliciting drug. A 35-year old male without previous known comorbidities was admitted after he was diagnosed with the COVID-19 infection and had large pulmonary involvement. Seven days later, he desaturated but was without any signs of respiratory distress. A check of arterial blood gas revealed normal partial pressure of oxygen and follow-up tests confirmed a methemoglobinemia diagnosis. Over the next few days, hemolysis was established after decreased levels of hemoglobin and increased levels of indirect bilirubin and lactate dehydrogenase. A hemolytic anemia investigation panel came back normal, including G6PD. A second G6PD test was ordered at the 5-month follow-up appointment and revealed decreased levels. Clinicians should thus be aware of possible false negative tests when testing for G6PD during hemolytic crisis. In addition, whether the COVID-19 infection alone would be responsible for this chain of events remains a challenging question.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.idcr.2020.e01013
?:journal
  • IDCases
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/811903a8013e011a555cefc2bb15daf06adea0b3.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7676365.xml.json
?:pmcid
?:pmid
?:pmid
  • 33235826.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Methemoglobinemia and Hemolytic Anemia after COVID-19 Infection Without Identifiable Eliciting Drug: A Case-Report
?:type
?:year
  • 2020-11-19

Metadata

Anon_0  
expand all